New diabetes clinical trial: Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

Published on: March 04, 2024 at 11:00PM
Conditions: Hypertension; Hypercholesterolemia
Interventions: Drug: Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg
Sponsors: Yuhan Corporation
Active, not recruiting
https://ift.tt/PS2DlI9